Yüklüyor......
Intrathecally produced CXCL13: A predictive biomarker in multiple sclerosis
BACKGROUND: Clinicians caring for patients with Multiple Sclerosis (MS) need improved biomarkers to aid them in disease management. OBJECTIVE: We assessed the predictive value of the candidate biomarker CXCL13 index in comparison to oligoclonal bands (OCBs) and CSF neurofilament light (NfL) concentr...
Kaydedildi:
| Yayımlandı: | Mult Scler J Exp Transl Clin |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publications
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7747124/ https://ncbi.nlm.nih.gov/pubmed/33403120 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217320981396 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|